Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Centralization of Syngenta GMO Corn Lawsuits to be Considered by MDL Panel November 20, 2014 Austin Kirk Add Your Comments A panel of federal judges is scheduled to hear oral arguments next month about whether all Syngenta GMO corn seed lawsuits should be centralized before one judge, consolidating claims brought by farmers and others in the corn industry that allege the genetically modified seed has caused sharp drops in the price of U.S. corn. Syngenta faces a growing number of lawsuits over sales of Agisure Viptera and Agisure Duracade corn seed, which is a genetically modified organism (GMO) that features a trait known as MIR162. According to the complaints, Syngenta misled farmers about the GMO corn by marketing the product without ensuring that crops with the trait could be exported to China, which is the third largest importer of U.S. corn. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Since November 2013, China has rejected corn with any trace of MIR162. As a result of co-mingling of corn grown by different farmers and cross-pollination caused by Syngenta’s instructions to grow Agisure Viptera GMO seed next to other corn, most of the U.S. corn supply is now unable to be exported to China. Plaintiffs claim that the negligent and reckless marketing of Syngenta CMO corn seed may cause the farm industry to suffer damages between $1 billion and $2.9 billion. As the number of complaints filed in U.S. District Courts throughout the country by farmers, landowners, transporters, exporters and others in the industry continues to mount, a motion was filed that seeks to centralize the GMO corn lawsuits as part of a federal MDL, or Multidistrict Litigation. The U.S. Judicial Panel on Multidistrict Litigation is scheduled to hear oral arguments on December 4 over whether all of the cases should be transferred to one judge for coordinated handling during pretrial proceedings, which may reduce duplicative discovery into common issues, avoid conflicting rulings from different courts and serve the convenience of the parties, witnesses and the courts. Location of MDL for Syngenta GMO Corn Lawsuits in Dispute While responses filed by Syngenta and many plaintiffs involved in the litigation support centralizing the cases, the parties disagree about the most appropriate venue for the MDL proceedings. The original motion to transfer (PDF) the litigation was filed by a group of plaintiffs last month, when there were at least nine Syngenta GMO corn class action lawsuits and one non-class action pending in nine different federal district courts. “Syngenta’s commercialization of MIR162 without approval from all key export markets, including China, and Syngenta’s promotion of commingling-enhancing growing practices, combined with China’s zero-tolerance policy toward unapproved genetic traits and China’s subsequent rejection of several U.S. corn shipments due to detection of trace amounts of MIR162 since November 2013, has resulted in serious trade disruptions, lower prices for U.S. commodity corn, and increased costs for U.S. elevator operators and exportes,” plaintiffs’ attorneys said in their motion to transfer. “Put simply, Syngenta’s common actions with respect to MIR162, while profitable for Syngenta, have caused and continue to cause widespread damage to a large number of stakeholders in the U.S. corn marketing system, many of whom have recently filed lawsuits in different courts around the country seeking to hold Syngenta accountable for its wrongful acts.” Plaintiffs have proposed centralizing the Syngenta GMO corn litigation in Illinois, indicating that it is the second-largest corn producing state in the country and that it is the home to the Chicago Board of Trade, where commodity corn is traded. In addition, plaintiffs maintain that Chicago is a major metropolitan area that is easily accessible and centrally located for those involved in lawsuits pending throughout the country. In a response (PDF) filed by Syngenta, the manufacturer argues that the District of Minnesota is a more appropriate transfer venue, since it is home to the company’s headquarters and at least three of the pending lawsuits have been filed in that state. Tags: Class Action Lawsuit, Duracade, Genetically Modified Organisms, GMO, Syngenta, Viptera More Syngenta Corn Lawsuit Stories Syngenta Corn Seed Settlement to Result in $1.4B in Payments to U.S. Farmers September 27, 2017 Syngenta Corn Seed Lawsuit Results in $218 Million Verdict for Farmers June 26, 2017 Syngenta Lawsuits Over Viptera, Duracade Corn Seed Allowed to Move Forward September 24, 2015 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Paraquat Lawsuits Over Parkinson’s Disease Continue To Be Filed, As MDL Stay Extended (Posted: today) Syngenta and Chevron continue to face a growing number of Paraquat lawsuits as the parties attempt to finalize a settlement agreement. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Parkinson’s Disease Settlement Payout Amounts Still Being Finalized (10/03/2025)Paraquat MDL Lawsuit Deadlines Extended Again, as Settlement Details Finalized (08/12/2025)Pesticide Exposure Could Lead to Higher Rheumatoid Arthritis Risks for Women Farm Workers: Study (07/23/2025) Sports Betting Problems Surge As More Americans Gamble Online, Survey Finds (Posted: 2 days ago) A new survey finds increasing rates in problem gambling throughout the state of Maryland since the legalization of mobile sports betting apps. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITClass Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (12/09/2025)Lawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025) Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: 3 days ago) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)
Paraquat Lawsuits Over Parkinson’s Disease Continue To Be Filed, As MDL Stay Extended (Posted: today) Syngenta and Chevron continue to face a growing number of Paraquat lawsuits as the parties attempt to finalize a settlement agreement. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Parkinson’s Disease Settlement Payout Amounts Still Being Finalized (10/03/2025)Paraquat MDL Lawsuit Deadlines Extended Again, as Settlement Details Finalized (08/12/2025)Pesticide Exposure Could Lead to Higher Rheumatoid Arthritis Risks for Women Farm Workers: Study (07/23/2025)
Sports Betting Problems Surge As More Americans Gamble Online, Survey Finds (Posted: 2 days ago) A new survey finds increasing rates in problem gambling throughout the state of Maryland since the legalization of mobile sports betting apps. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITClass Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (12/09/2025)Lawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)
Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: 3 days ago) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)